SAN DIEGO, July 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today announced it will report second quarter 2006 financial results after the NASDAQ Global Market closes on Tuesday, July 25, 2006. That same afternoon, Jack Lief, Arena’s President and Chief Executive Officer, and Robert E. Hoffman, Arena’s Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the second quarter 2006 financial results and to provide a corporate update.
The conference call may be accessed by dialing 800.688.0836 for domestic callers and 617.614.4072 for international callers. Please specify to the operator that you would like to join the “Arena Second Quarter 2006 Earnings Call.” The conference call will be webcast live under the investor relations section of Arena’s website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focusing its research and development efforts on small molecule drugs in four major therapeutic areas: metabolic, central nervous system, cardiovascular and inflammatory diseases. Arena has a broad pipeline of compounds targeting an important class of drug targets called G protein-coupled receptors, or GPCRs, using its knowledge of GPCRs and its technologies, including CART(TM) and Melanophore. Arena has four internally discovered, clinical-stage drug candidates for major diseases. The most advanced, lorcaserin, is under investigation for the treatment of obesity. Arena’s lead drug candidate for the treatment of insomnia, APD125, is a compound with a novel mechanism of action. Arena also has two clinical-stage collaborations with major pharmaceutical companies: Merck & Co., Inc. and Ortho-McNeil, Inc.
Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. CART(TM) is an unregistered service mark of the company. “APD” is an abbreviation for Arena Pharmaceuticals Development.
Contacts: Jack Lief Carolyn Wang President and CEO WeissComm Partners Media Relations David Walsey 415.946.1065 Director, Corporate Communications Arena Pharmaceuticals 858.453.7200, ext. 1682
Arena Pharmaceuticals, Inc.
CONTACT: Jack Lief, President and CEO, or David Walsey, Director,Corporate Communications, both of Arena Pharmaceuticals, +1-858-453-7200,ext. 1682; or Carolyn Wang of WeissComm Partners, Media Relations,+1-415-946-1065, for Arena Pharmaceuticals, Inc.
Web site: http://www.arenapharm.com/
